What's new

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 26, Status: Authorised

May 14, 2025 - 14:18
 0
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 26, Status: Authorised
Human medicines European public assessment report (EPAR): Paxlovid, nirmatrelvir,ritonavir, Date of authorisation: 28/01/2022, Revision: 26, Status: Authorised
Read More

Tags:

Previous Article

Article 57 product data

Next Article

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine...

Related Posts

Overview of comments received on ICH E6(R3) guideline f...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Filsuvez, birch bark extract, Date of authorisation: 21/06/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Poteligeo, mogamulizumab, Date of authorisation: 22/11/2018, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

May 21, 2025  0